ABI
ARIA

Adamant Biomedical Investments’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Adamant Biomedical Investments’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.06M Hold
300,000
– – 0.49% 64
2014
Q3 		$1.62M Buy
+300,000
New +$1.75M 0.4% 67

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Adamant Biomedical Investments's ARIA Position: Q4 2014 in Review

Adamant Biomedical Investments held its Ariad Pharmaceuticals Inc (ARIA) position steady in Q4 2014 at 300,000 shares worth $2.06M. The position accounts for 0.49% of the portfolio, ranked #64.

Adamant Biomedical Investments first reported a position in ARIA in Q3 2014 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold ARIA as of Q4 2014.

  • Adamant Biomedical Investments held 300,000 shares of Ariad Pharmaceuticals Inc worth $2.06M as of Q4 2014.
  • Adamant Biomedical Investments left its Ariad Pharmaceuticals Inc share count unchanged in Q4 2014.
  • Ariad Pharmaceuticals Inc made up 0.49% of Adamant Biomedical Investments's portfolio in Q4 2014, its #64 holding.
  • Adamant Biomedical Investments first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.